Government plans decentralisation of ICT powers from SITA to state institutions
Government considers decentralising ICT procurement from SITA to state institutions to address delivery delays and improve ...
Combat the winter blues in Tri-Cities by pairing health recommendations with local options
When temperatures drop, it’s important to check for signs of the winter blues, or its more severe counterpart, Seasonal ...
Business Wire13h
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) ...
Anavex: Looking At Different Statistical Approaches Before EMA Opinion
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.